Procyanidin B-2 (Apple Polyphenol) for Alopecia Areata

Verdict: No evidence for alopecia areata; unverified

There is no human evidence that procyanidin B-2 (apple polyphenol) treats alopecia areata. Every existing human trial was conducted in a different, unrelated condition, so its benefit for autoimmune patchy hair loss is unverified, not established.

U ⚫ U Unverified Insufficient Evidence

🔬Why this grade7-layer evidence engine

A PubMed search found zero clinical trials of procyanidin B-2 in alopecia areata of any design. The only human RCTs (Takahashi et al., PMID 11194183 and PMID 11406858, each n=29) enrolled men with androgenetic alopecia (pattern baldness), a fundamentally different disease, and a 2018 systematic review of complementary alopecia treatments (PMID 30815439) lists the compound only under androgenetic alopecia, omitting it from the alopecia areata section.

Mechanism also argues against extrapolation. A laboratory study (PMID 11841365) shows procyanidin B-2 acts by downregulating protein kinase C isozymes and pushing follicles from rest into the growth phase. That hair-cycle pathway is off-target for alopecia areata, which is driven by a CD8+ T-cell autoimmune attack on the follicle and is treated with corticosteroids and JAK inhibitors.

Authorities add nothing supportive: the FDA recognizes apple polyphenol extract only as a safe food ingredient (GRAS), EFSA rejected procyanidin health claims because a cause-and-effect relationship has not been established, and major clinical bodies do not address it. With no condition-specific data and industry-funded source studies, the engine rates it Unverified (U) pending more evidence.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.41
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
80%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.20
L2 PubMedPrimary literature
0.40
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.406
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent (Takahashi et al.)
PMID: 11406858 2001 RCT (double-blind) n = 29
Finding: 78.9% of treated vs 30.0% of placebo subjects showed increased mean hair diameter (p<0.02); hair count change +3.67±4.09 vs −2.54±4.00 hairs/0.25 cm² (p<0.001). Population was male androgenetic alopecia (AGA), NOT alopecia areata; this study provides no direct AA evidence.
🟠 Limited quality ⚠️ Industry-funded Effect size: +6.21 hairs/0.25 cm² vs placebo (AGA population, not AA)
View on PubMed
Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent (Takahashi et al.)
PMID: 11194183 2000 RCT (double-blind) n = 29
Finding: Total hair increase +6.68±5.53 (treatment) vs +0.08±4.56 (placebo), p<0.005; terminal hair +1.99±2.58 vs −0.82±3.40, p<0.02. Same Kyowa Hakko group; population again male AGA, NOT alopecia areata.
🟠 Limited quality ⚠️ Industry-funded Effect size: +6.60 hairs/0.25 cm² vs placebo (AGA population, not AA)
View on PubMed
Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study (Kamimura & Takahashi)
PMID: 11841365 2002 Animal Study
Finding: Procyanidin B-2 down-regulates telogen-specific PKC isozymes and accelerates telogen→anagen transition in C3H mice. Mechanism targets anagen induction in normal follicles, NOT the CD8+ T-cell / NKG2D-mediated peribulbar autoimmune attack that defines alopecia areata. No murine AA model (e.g. C3H/HeJ spontaneous AA) was used.
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
Complementary and alternative treatments for alopecia: a comprehensive review (Hosking, Juhasz, Atanaskova Mesinkovska)
PMID: 30815439 2018 系統性回顧
Finding: Review discusses procyanidin B-2 only under androgenetic alopecia (Takahashi trials); the alopecia areata section covers onion juice, garlic gel, aromatherapy, capsaicin, zinc and vitamin D — procyanidin B-2 is NOT listed among CAM interventions with any clinical evidence in AA. Confirms absence of AA-specific clinical data for procyanidin B-2 as of 2018.
Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Apple polyphenol extract (Applephenon) is generally recognized as safe (GRAS) under the intended conditions of use as a food ingredient source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of proanthocyanidins from various sources and the maintenance of normal blood pressure / maintenance of normal blood flow / protection of body lipids from oxidative damage / maintenance of normal vascular function source↗
L4d TW TFDA / 衛福部
Neutral
本署公告之健康食品保健功效項目共十三項:護肝(針對化學性肝損傷)、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。食品(含一般食品及健康食品)之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形,亦不得涉及醫療效能。 source↗
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-alopecia-areata-INT-procyanidin-b-2-001 繁體中文版 →